Suau, A., Bonnet, R., Sutren, M., Godon, J. J., Gibson, G. R., Collins, M. D., & Doré, J. (1999). Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Applied and Environment Microbiology, 65(11), 4799–4807. https://doi.org/10.1128/aem.65.11.4799-4807.1999
Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., & Kasper, D. L. (2005). An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell, 122(1), 107–118. https://doi.org/10.1016/j.cell.2005.05.007
CAS Article PubMed Google Scholar
Nakatsuji, T., Chen, T. H., Narala, S., Chun, K. A., Two, A. M., Yun, T., Shafiq, F., Kotol, P. F., Bouslimani, A., Melnik, A. V., Latif, H., Kim, J. N., Lockhart, A., Artis, K., David, G., Taylor, P., Streib, J., Dorrestein, P. C., Grier, A., Gill, S. R., et al. (2017). Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med, 9(378). https://doi.org/10.1126/scitranslmed.aah4680
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012). Interactions between the microbiota and the immune system. Science, 336(6086), 1268–1273. https://doi.org/10.1126/science.1223490
CAS Article PubMed PubMed Central Google Scholar
Lee, Y. K., & Mazmanian, S. K. (2010). Has the microbiota played a critical role in the evolution of the adaptive immune system? Science, 330(6012), 1768–1773. https://doi.org/10.1126/science.1195568
CAS Article PubMed PubMed Central Google Scholar
Chen, D. S., & Mellman, I. (2017). Elements of cancer immunity and the cancer-immune set point. Nature, 541(7637), 321–330. https://doi.org/10.1038/nature21349
CAS Article PubMed Google Scholar
Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M., & Salminen, S. (2007). Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Applied and Environment Microbiology, 73(23), 7767–7770. https://doi.org/10.1128/aem.01477-07
Fluckiger, A., Daillère, R., Sassi, M., Sixt, B. S., Liu, P., Loos, F., Richard, C., Rabu, C., Alou, M. T., Goubet, A.-G., Lemaitre, F., Ferrere, G., Derosa, L., Duong, C. P. M., Messaoudene, M., Gagné, A., Joubert, P., Sordi, L. D., Debarbieux, L., Simon, S., et al. (2020). Cross-reactivity between tumor MHC class I– restricted antigens and an enterococcal bacteriophage. Science, 369(6506), 936–942. https://doi.org/10.1126/science.aax0701
CAS Article PubMed Google Scholar
Nishida, A., Inoue, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2018). Gut microbiota in the pathogenesis of inflammatory bowel disease. Clinical Journal of Gastroenterology, 11(1), 1–10. https://doi.org/10.1007/s12328-017-0813-5
Blaser, M. J. (2016). Antibiotic use and its consequences for the normal microbiome. Science, 352(6285), 544–545. https://doi.org/10.1126/science.aad9358
CAS Article PubMed PubMed Central Google Scholar
Holota, Y., Dovbynchuk, T., Kaji, I., Vareniuk, I., Dzyubenko, N., Chervinska, T., Zakordonets, L., Stetska, V., Ostapchenko, L., Serhiychuk, T., & Tolstanova, G. (2019). The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity. PLoS ONE, 14(8), e0220642–e0220642. https://doi.org/10.1371/journal.pone.0220642
CAS Article PubMed PubMed Central Google Scholar
Palleja, A., Mikkelsen, K. H., Forslund, S. K., Kashani, A., Allin, K. H., Nielsen, T., Hansen, T. H., Liang, S., Feng, Q., Zhang, C., Pyl, P. T., Coelho, L. P., Yang, H., Wang, J., Typas, A., Nielsen, M. F., Nielsen, H. B., Bork, P., Wang, J., Vilsbøll, T., et al. (2018). Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology, 3(11), 1255–1265. https://doi.org/10.1038/s41564-018-0257-9
CAS Article PubMed Google Scholar
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., Patil, K. R., Bork, P., & Typas, A. (2018). Extensive impact of non-antibiotic drugs on human gut bacteria. Nature, 555(7698), 623–628. https://doi.org/10.1038/nature25979
CAS Article PubMed PubMed Central Google Scholar
Jackson, M. A., Goodrich, J. K., Maxan, M. E., Freedberg, D. E., Abrams, J. A., Poole, A. C., Sutter, J. L., Welter, D., Ley, R. E., Bell, J. T., Spector, T. D., & Steves, C. J. (2016). Proton pump inhibitors alter the composition of the gut microbiota. Gut, 65(5), 749–756. https://doi.org/10.1136/gutjnl-2015-310861
CAS Article PubMed Google Scholar
Pierrard, J., & Seront, E. (2019). Impact of the gut microbiome on immune checkpoint inhibitor efficacy-a systematic review. Current Oncology, 26(6), 395–403. https://doi.org/10.3747/co.26.5177
CAS Article PubMed PubMed Central Google Scholar
Li, J., Jia, H., Cai, X., Zhong, H., Feng, Q., Sunagawa, S., Arumugam, M., Kultima, J. R., Prifti, E., Nielsen, T., Juncker, A. S., Manichanh, C., Chen, B., Zhang, W., Levenez, F., Wang, J., Xu, X., Xiao, L., Liang, S., Zhang, D., et al. (2014). An integrated catalog of reference genes in the human gut microbiome. Nature Biotechnology, 32(8), 834–841. https://doi.org/10.1038/nbt.2942
CAS Article PubMed Google Scholar
Lozupone, C., Lladser, M. E., Knights, D., Stombaugh, J., & Knight, R. (2011). UniFrac: An effective distance metric for microbial community comparison. ISME Journal, 5(2), 169–172. https://doi.org/10.1038/ismej.2010.133
Manchester, M., & Anand, A. (2017). Chapter Two - Metabolomics: Strategies to define the role of metabolism in virus infection and pathogenesis. In M. Kielian, T. C. Mettenleiter, & M. J. Roossinck (Eds.), Advances in virus research (Vol. 98, pp. 57–81). Academic Press. https://doi.org/10.1016/bs.aivir.2017.02.001
McDonald, D., Price, M. N., Goodrich, J., Nawrocki, E. P., DeSantis, T. Z., Probst, A., Andersen, G. L., Knight, R., & Hugenholtz, P. (2012). An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME Journal, 6(3), 610–618. https://doi.org/10.1038/ismej.2011.139
CAS Article PubMed Google Scholar
Davis, C., Kota, K., Baldhandapani, V., Gong, W., Abubucker, S., Becker, E., Martin, J., Wylie, K. M., Khetani, R., Hudson, M. E., Weinstock, G. M., & Mitreva, M. (2015). mBLAST: Keeping up with the sequencing explosion for (meta)genome analysis. J Data Mining Genomics Proteomics, 4(3). https://doi.org/10.4172/2153-0602.1000135
Johnson, J. S., Spakowicz, D. J., Hong, B.-Y., Petersen, L. M., Demkowicz, P., Chen, L., Leopold, S. R., Hanson, B. M., Agresta, H. O., Gerstein, M., Sodergren, E., & Weinstock, G. M. (2019). Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nature Communications, 10(1), 5029. https://doi.org/10.1038/s41467-019-13036-1
CAS Article PubMed PubMed Central Google Scholar
Grim, C. J., Daquigan, N., Lusk Pfefer, T. S., Ottesen, A. R., White, J. R., & Jarvis, K. G. (2017). High-resolution microbiome profiling for detection and tracking of Salmonella enterica. Frontiers in Microbiology, 8, 1587. https://doi.org/10.3389/fmicb.2017.01587
Article PubMed PubMed Central Google Scholar
Brumfield, K. D., Huq, A., Colwell, R. R., Olds, J. L., & Leddy, M. B. (2020). Microbial resolution of whole genome shotgun and 16S amplicon metagenomic sequencing using publicly available NEON data. PLoS ONE, 15(2), e0228899. https://doi.org/10.1371/journal.pone.0228899
Article PubMed PubMed Central Google Scholar
Durazzi, F., Sala, C., Castellani, G., Manfreda, G., Remondini, D., & De Cesare, A. (2021). Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. Science and Reports, 11(1), 3030. https://doi.org/10.1038/s41598-021-82726-y
Kuczynski, J., Lauber, C. L., Walters, W. A., Parfrey, L. W., Clemente, J. C., Gevers, D., & Knight, R. (2011). Experimental and analytical tools for studying the human microbiome. Nature Reviews Genetics, 13(1), 47–58. https://doi.org/10.1038/nrg3129
CAS Article PubMed PubMed Central Google Scholar
Keegan, K. P., Glass, E. M., & Meyer, F. (2016). MG-RAST, a metagenomics service for analysis of microbial community structure and function. Methods in Molecular Biology, 1399, 207–233. https://doi.org/10.1007/978-1-4939-3369-3_13
CAS Article PubMed Google Scholar
Beghini, F., McIver, L. J., Blanco-Miguez, A., Dubois, L., Asnicar, F., Maharjan, S., Mailyan, A., Manghi, P., Scholz, M., Thomas, A. M., Valles-Colomer, M., Weingart, G., Zhang, Y., Zolfo, M., Huttenhower, C., Franzosa, E. A., & Segata, N. (2021). Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife, 10. https://doi.org/10.7554/eLife.65088
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., Schlitzer, A., Ginhoux, F., Apetoh, L., Chachaty, E., Woerther, P. L., Eberl, G., Bérard, M., Ecobichon, C., Clermont, D., Bizet, C., et al. (2013). The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science, 342(6161), 971–976. https://doi.org/10.1126/science.1240537
CAS Article PubMed PubMed Central Google Scholar
Daillère, R., Vétizou, M., Waldschmitt, N., Yamazaki, T., Isnard, C., Poirier-Colame, V., Duong, C. P. M., Flament, C., Lepage, P., Roberti, M. P., Routy, B., Jacquelot, N., Apetoh, L., Becharef, S., Rusakiewicz, S., Langella, P., Sokol, H., Kroemer, G., Enot, D., Roux, A., et al. (2016). Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity, 45(4), 931–943. https://doi.org/10.1016/j.immuni.2016.09.009
CAS Article PubMed Google Scholar
Oh, B., Boyle, F., Pavlakis, N., Clarke, S., Guminski, A., Eade, T., Lamoury, G., Carroll, S., Morgia, M., Kneebone, A., Hruby, G., Stevens, M., Liu, W., Corless, B., Molloy, M., Libermann, T., Rosenthal, D., & Back, M. (2021). Emerging evidence of the gut microbiome in chemotherapy: A clinical review [Mini Review]. Front Oncol, 11. https://doi.org/10.3389/fonc.2021.706331
Zhao, Z., Fei, K., Bai, H., Wang, Z., Duan, J., & Wang, J. (2021). Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer. Thorac Cancer, 12(1), 66–78. https://doi.org/10.1111/1759-7714.13711
CAS Article PubMed Google Scholar
McQuade, J. L., Daniel, C. R., Helmink, B. A., & Wargo, J. A. (2019). Modulating the microbiome to improve therapeutic response in cancer. The Lancet Oncology, 20(2), e77–e91. https://doi.org/10.1016/S1470-2045(18)30952-5
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004). The three Es of cancer immunoediting. Annual Review of Immunology, 22, 329–360. https://doi.org/10.1146/annurev.immunol.22.012703.104803
CAS Article PubMed Google Scholar
Naidoo, J., Page, D. B., & Wolchok, J. D. (2014). Immune checkpoint blockade. Hematology/oncology Clinics of North America, 28(3), 585–600. https://doi.org/10.1016/j.hoc.2014.02.002
Reck, M., Rodriguez-Abreu, D., Robinson, A. G., Hui, R., Csoszi, T., Fulop, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., O’Brien, M., Rao, S., Hotta, K., Leiby, M. A., Lubiniecki, G. M., Shentu, Y., Rangwala, R., Brahmer, J. R., & Investigators, K.-. (2016). Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med, 375(19), 1823-1833. https://doi.org/10.1056/NEJMoa1606774
Mok, T. S. K., Wu, Y.-L., Kudaba, I., Kowalski, D. M., Cho, B. C., Turna, H. Z., Castro, G., Jr., Srimuninnimit, V., Laktionov, K. K., Bondarenko, I., Kubota, K., Lubiniecki, G. M., Zhang, J., Kush, D., Lopes, G., Adamchuk, G., Ahn, M.-J., Alexandru, A., Altundag, O., Alyasova, A., et al. (2019). Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): A randomised, open-label, controlled, phase 3 trial. The Lancet, 393(10183), 1819–1830. https://doi.org/10.1016/S0140-6736(18)32409-7
留言 (0)